FRONTEO Inc. (Headquarters: Minato-ku, Tokyo; Representative Board of Director and President: Masahiro Morimoto; hereinafter referred to as FRONTEO) is pleased to announce that it has begun offering "KIBIT Eye," an AI solution developed by FRONTEO that predicts fraud risks, to Mitsubishi UFJ Morgan Stanley Securities Co., Ltd. (hereinafter referred to as "Mitsubishi UFJ Morgan Stanley Securities").

The decision to deploy this system was made possible due to the recognition of the specialized AI "KIBIT"'s high analytical accuracy and its track record of implementation within the Mitsubishi UFJ Financial Group*.

In recent years, the environment surrounding the financial industry has been changing rapidly, and financial institutions are being asked to ensure greater transparency and proper business operations. In particular, thorough customer protection, prevention of internal fraud, strengthening anti-cartel measures, and cybersecurity measures in line with the advancement of digitalization are being seen as important social and industry issues.

To address these issues, KIBIT Eye will improve the comprehensiveness of fraud monitoring and enhance verification accuracy, further strengthening Mitsubishi UFJ Morgan Stanley Securities' compliance system.

Through KIBIT Eye, FRONTEO will continue to support Mitsubishi UFJ Morgan Stanley Securities in strengthening its compliance efforts.

*KIBIT Eye will be launched in April 2024 by Mitsubishi UFJ Trust and Banking Corporation.¹⁾, Mitsubishi UFJ Bank in March 2025²⁾It has been introduced in.

 1) Press release dated April 2024, 4:
     Mitsubishi UFJ Trust Bank introduces AI solution "KIBIT Eye", https://www.fronteo.com/20240423

 2) Press release dated April 2025, 3:
     FRONTEO begins offering "KIBIT Eye," an AI solution that predicts fraud risks, to Mitsubishi UFJ Bank, 
     https://www.fronteo.com/pr/20250325

About KIBIT Eye　URL:https://kibit.fronteo.com/products/kibit-eye/

KIBIT Eye is an AI solution that uses our proprietary specialized AI "KIBIT" (patented in Japan and the U.S.) to help companies detect risks early and predict fraud.

By using AI to analyze huge volumes of text data, it is possible to eliminate personal bias in judgment criteria and enable uniform and comprehensive checks. In addition, by scoring data, it is possible to extract data that is likely to contain risks, allowing for effective risk management and contributing to the sophistication of operations.

■ About FRONTEO　URL:https://www.fronteo.com/

FRONTEO supports the judgment of experts in various fields who face social issues day and night through the provision of its proprietary specialized AI "KIBIT," and creates the starting point for innovation. Unlike general-purpose AI, our proprietary natural language processing technology (patented in Japan and the United States) enables high-speed and high-precision analysis without relying on the amount of training data or computing power. In addition, by utilizing patented technology that maps (visualizes the structure) the analyzed information, "KIBIT" can directly influence the insights of experts, and in recent years, KIBIT's technology has also been used in hypothesis generation and target discovery in drug discovery.

Through KIBIT's unique technology and approach, we aim to realize our philosophy of "providing solutions that do not overlook risks and opportunities hidden in records, and realizing fairness in the information society."Life science AI, Risk Management (Compliance Support Area,economic security field,Legal Tech AI field), DX (Professional Support Areas) and promotes social implementation in each of our businesses.

Founded in August 2003, the company was listed on the Tokyo Stock Exchange Mothers (now the Tokyo Stock Exchange Growth) on June 8, 2007.
The company operates in Japan, the United States, South Korea and Taiwan.
Obtained Type 1 medical device manufacturing and sales license and registered as a controlled medical device sales business.
Capital: 899,176 yen (as of March 2025, 3).

*FRONTEO, KIBIT, and KIBIT Eye are trademarks or registered trademarks of FRONTEO in Japan, Europe, the United States, and Korea.